Part,  Chapter, Paragraph

1  III,    10.  4.  2|     i.e. compounds that show dose-addition) has been put forward. Several
2  III,    10.  4.  2|     a common mode of action (dose-addition), for which data are already
3  III,    10.  4.  2| prioritised for work on CRA (dose-addition) are: oligophosphates, carbamates,